JP2021523379A5 - - Google Patents

Info

Publication number
JP2021523379A5
JP2021523379A5 JP2020564247A JP2020564247A JP2021523379A5 JP 2021523379 A5 JP2021523379 A5 JP 2021523379A5 JP 2020564247 A JP2020564247 A JP 2020564247A JP 2020564247 A JP2020564247 A JP 2020564247A JP 2021523379 A5 JP2021523379 A5 JP 2021523379A5
Authority
JP
Japan
Prior art keywords
subject
inhibit
biomarkers
treatment
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020564247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021523379A (ja
Filing date
Publication date
Priority claimed from GBGB1807789.1A external-priority patent/GB201807789D0/en
Priority claimed from GBGB1816764.3A external-priority patent/GB201816764D0/en
Priority claimed from GBGB1817024.1A external-priority patent/GB201817024D0/en
Application filed filed Critical
Priority claimed from PCT/EP2019/062215 external-priority patent/WO2019219612A1/en
Publication of JP2021523379A publication Critical patent/JP2021523379A/ja
Publication of JP2021523379A5 publication Critical patent/JP2021523379A5/ja
Pending legal-status Critical Current

Links

JP2020564247A 2018-05-14 2019-05-13 血清バイオマーカー Pending JP2021523379A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1807789.1A GB201807789D0 (en) 2018-05-14 2018-05-14 Serum biomarkers
GB1807789.1 2018-05-14
GBGB1816764.3A GB201816764D0 (en) 2018-10-15 2018-10-15 Serum biomarkers
GB1816764.3 2018-10-15
GBGB1817024.1A GB201817024D0 (en) 2018-10-19 2018-10-19 Serum biomarkers
GB1817024.1 2018-10-19
PCT/EP2019/062215 WO2019219612A1 (en) 2018-05-14 2019-05-13 Serum biomarkers

Publications (2)

Publication Number Publication Date
JP2021523379A JP2021523379A (ja) 2021-09-02
JP2021523379A5 true JP2021523379A5 (enExample) 2022-05-20

Family

ID=66589527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564247A Pending JP2021523379A (ja) 2018-05-14 2019-05-13 血清バイオマーカー

Country Status (5)

Country Link
US (1) US20210215697A1 (enExample)
EP (1) EP3794352A1 (enExample)
JP (1) JP2021523379A (enExample)
CN (1) CN112639474A (enExample)
WO (1) WO2019219612A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004189D0 (en) * 2020-03-23 2020-05-06 Bergenbio As Combination therapy
CA3202255A1 (en) 2020-12-21 2022-06-30 Hayley WARSINSKE Markers for the early detection of colon cell proliferative disorders
US20230104609A1 (en) * 2021-10-04 2023-04-06 Tintoria Piana, Inc Diagnostic system and methods of using and manufacturing the same
CN118359697A (zh) * 2024-04-29 2024-07-19 上海硅羿生物技术有限公司 β淀粉样蛋白40及β淀粉样蛋白42特异识别多肽及其应用
CN121186348B (zh) * 2025-11-25 2026-02-24 北京大学人民医院 瓜氨酸化内凝集素-1多肽在制备类风湿关节炎诊断产品中的应用
CN121186365B (zh) * 2025-11-25 2026-04-14 长兴固容生物科技有限公司 一种用于胰腺癌筛查、诊断的标志物组及其用途
CN121186360B (zh) * 2025-11-25 2026-04-14 长兴固容生物科技有限公司 一种用于乳腺癌筛查、诊断的标志物组及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
AU2006247067B2 (en) * 2005-05-18 2012-06-07 Novartis Ag Methods for diagnosis and treatment of proliferative disorders mediated by CD40 signaling
EP2904115B1 (en) * 2012-10-01 2018-08-08 Millennium Pharmaceuticals, Inc. Biomarkers and methods to predict response to inhibitors and uses thereof
GB201410825D0 (en) * 2014-06-18 2014-07-30 Bergenbio As Anti-axl antibodies
GB201410826D0 (en) 2014-06-18 2014-07-30 Bergenbio As Anti-axl antibodies
AU2015366213B2 (en) * 2014-12-18 2021-10-07 Bergenbio Asa Anti-Axl antagonistic antibodies
JP6787899B2 (ja) 2014-12-23 2020-11-18 ベルゲンビオ アーエスアー 医薬的活性化合物
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201512133D0 (en) * 2015-07-10 2015-08-19 Bergenbio As Biomarkers

Similar Documents

Publication Publication Date Title
JP2021523379A5 (enExample)
JP6630766B2 (ja) 膵臓癌診断用組成物およびこれを用いた膵臓癌診断方法
Chen et al. Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia
KR102185987B1 (ko) Ripk3을 포함하는 당뇨병성 신증 진단용 바이오마커 및 이의 용도
KR20170129118A (ko) 췌장암을 위한 바이오마커
KR102442803B1 (ko) 결장직장암에 대한 복합 테스트
JP2023539867A5 (enExample)
Xu et al. Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma
US20090298097A1 (en) Methods for the diagnosis of lung cancer
CN106662543A (zh) 肺癌患者中的非侵入性基因突变检测
JP2018529931A5 (enExample)
Choi et al. Clinical value of full-length tryptophanyl-tRNA synthetase for sepsis detection in critically ill patients—A retrospective clinical assessment
JP2025518766A (ja) 胃癌発病可能性の予測のためのバイオマーカー及びその用途
Lee et al. Ischemia-modified albumin: a novel blood marker of endoscopic mucosal healing in inflammatory bowel disease
US20120156681A1 (en) Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof
US20250197944A1 (en) Differential diagnosis method
WO2011148669A1 (ja) 大腸がんマーカービトロネクチン、及び採血試料中のビトロネクチン濃度の分析方法
KR20200049647A (ko) 반려동물에서 종양질병의 보조적 진단을 위한 바이오마커 검사방법
KR102453551B1 (ko) 급성 췌장염 중증도 진단용 정보 제공 방법
KR20130040294A (ko) 소세포폐암 진단용 조성물 및 소세포폐암 진단키트
JP6145650B2 (ja) 卵巣癌マーカー及び卵巣癌検出方法
KR20220129816A (ko) 미만형 위암의 예후 진단 마커
CN113981092A (zh) 用于预测肿瘤药物敏感性的生物标志物及其相关产品
CN113999911A (zh) 用于黑色素瘤免疫治疗药物敏感性预测的产品及用途
KR102735773B1 (ko) 혈액 내 단백질 바이오마커를 포함하는 암 진단용 키트